Dear Colleagues, We are in a challenging time as the COVID-19 pandemic rapidly accelerates in New York City. Healthcare providers will need to make critical decisions that are far different than the normal practice of medicine and will like... Read More >

Outpatient testing must not be encouraged, promoted or advertised. Persons with COVID-like illness not requiring hospitalization should be instructed to stay home. It is safer for the patients and health care workers and testing does not cu... Read More >

Co-Diagnostics has been part of the coronavirus conversation for the past two months. Whether its been educating the public about the disease or developing diagnostics for the virus, the company has been at the forefront. Now the Salt Lake... Read More >

Reorg Research reported that Medtronic is in early-stage acquisition talks withLivaNova, news that has been well received by LivaNova shareholders. The firm said Medtronic would subsequently break up LivaNova, keeping its neuromodulation bu... Read More >

FDA is upping its response to address the novel coronavirus outbreak. The policy is aimed at laboratories seeking to develop diagnostic tests for the coronavirus. The policy allows laboratories to develop and begin to use the diagnostics be... Read More >

Quest Diagnostics joins the growing number of firms that have developed tests for the coronavirus (COVID-19) in recent weeks.The Secaucus, NJ-based company said it was launching its COVID-19 test service that aids in the presumptive detecti... Read More >

NEW YORK The US Food and Drug Administration on Friday granted Emergency Use Authorization to Luminex for the firms NxTag CoV Extended Panel to detect SARS-CoV-2 virus nucleic acids in nasopharyngeal swab specimens. High-complexity molecula... Read More >

NEW YORK Avellino Labs on March 25 received Emergency Use Authorization for its coronavirus real-time PCR diagnostic test from the US Food and Drug Administration. The assay, called AvellinoCoV2 test, is designed for the detection of nuclei... Read More >

NEW YORK Sysmex said Friday it has obtained marketing approval in Japan for the distribution of BGI Genomics 2019-nCoV Fluorescence Detection Real-Time RT-PCR Kit. Financial and other terms of the agreement were not disclosed. Sysmex said t... Read More >

NEW YORK Fosun Pharmaceutical said on Thursday that its Fosun Long March Medical Science subsidiary has received emergency approval from Chinas National Medical Products Administration for a SARS-CoV-2 detection kit. According to Shanghai,... Read More >